These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells. Horny HP; Sotlar K; Valent P Immunol Allergy Clin North Am; 2014 May; 34(2):315-21. PubMed ID: 24745676 [TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches. Valent P; Akin C; Gleixner KV; Sperr WR; Reiter A; Arock M; Triggiani M Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216696 [TBL] [Abstract][Full Text] [Related]
8. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL. Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351 [TBL] [Abstract][Full Text] [Related]
9. Bone Marrow Expression of Mast Cell Disorders. Sánchez-Muñoz L; Henriques AF; Alvarez-Twose I; Matito A Immunol Allergy Clin North Am; 2018 Aug; 38(3):379-395. PubMed ID: 30007458 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. Valent P; Sperr WR; Schwartz LB; Horny HP J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic criteria and classification of mastocytosis in 2014. Akin C; Valent P Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670 [TBL] [Abstract][Full Text] [Related]
12. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice. Valent P; Hartmann K; Schwaab J; Alvarez-Twose I; Brockow K; Bonadonna P; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Sperr WR; Butterfield JH; Ustun C; Zanotti R; Radia DH; Castells M; Triggiani M; Schwartz LB; Orfao A; George TI; Sotlar K; Gotlib J; Reiter A; Horny HP; Arock M; Akin C; Metcalfe DD J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1999-2012.e6. PubMed ID: 35342031 [TBL] [Abstract][Full Text] [Related]
13. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val. Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687 [TBL] [Abstract][Full Text] [Related]
15. Current state of biology and diagnosis of clonal mast cell diseases in adults. Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157 [TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. Akin C J Mol Diagn; 2006 Sep; 8(4):412-9. PubMed ID: 16931579 [TBL] [Abstract][Full Text] [Related]
17. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment. Azaña JM; Torrelo A; Matito A Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106 [TBL] [Abstract][Full Text] [Related]
18. New Insights into the Pathogenesis of Mastocytosis: Emerging Concepts in Diagnosis and Therapy. Valent P; Akin C; Sperr WR; Horny HP; Arock M; Metcalfe DD; Galli SJ Annu Rev Pathol; 2023 Jan; 18():361-386. PubMed ID: 36270293 [TBL] [Abstract][Full Text] [Related]
19. The Role of KIT Mutations in Anaphylaxis. Coulson E; Zhou S; Akin C Curr Allergy Asthma Rep; 2019 Apr; 19(6):31. PubMed ID: 31028494 [TBL] [Abstract][Full Text] [Related]
20. Mastocytosis: a comprehensive insight. VAN Gysel D; DE Maeseneer H; Oranje AP G Ital Dermatol Venereol; 2016 Aug; 151(4):385-96. PubMed ID: 27070304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]